Ag2 R La Mondiale Gestion D'Actifs Regeneron Pharmaceuticals, Inc. Transaction History
Ag2 R La Mondiale Gestion D'Actifs
- $1.71 Billion
- Q1 2025
A detailed history of Ag2 R La Mondiale Gestion D'Actifs transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ag2 R La Mondiale Gestion D'Actifs holds 4,105 shares of REGN stock, worth $2.14 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
4,105Holding current value
$2.14 Million% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,472Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.9 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.4 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.95 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.5 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.08 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $55.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...